Welcome to LookChem.com Sign In|Join Free

CAS

  • or

302964-02-9

Post Buying Request

302964-02-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

302964-02-9 Usage

Chemical Properties

White solid

Check Digit Verification of cas no

The CAS Registry Mumber 302964-02-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,0,2,9,6 and 4 respectively; the second part has 2 digits, 0 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 302964-02:
(8*3)+(7*0)+(6*2)+(5*9)+(4*6)+(3*4)+(2*0)+(1*2)=119
119 % 10 = 9
So 302964-02-9 is a valid CAS Registry Number.
InChI:InChI=1/C9H12N2O4S/c1-9(2,3)15-8(14)11-7-10-4-5(16-7)6(12)13/h4H,1-3H3,(H,12,13)(H,10,11,14)

302964-02-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 11, 2017

Revision Date: Aug 11, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-[(tert-Butoxycarbonyl)amino]-1,3-thiazole-5-carboxylic acid

1.2 Other means of identification

Product number -
Other names 2-(N-BOC)-Aminothiazole-5-carboxylic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:302964-02-9 SDS

302964-02-9Relevant articles and documents

A convenient new and efficient commercial synthetic route for dasatinib (Sprycel)

Suresh, Garbapu,Nadh, Ratnakaram Venkata,Srinivasu, Navuluri,Yennity, Durgaprasad

, p. 1610 - 1621 (2017)

A new and efficient synthetic route for dual-Src/Abl kinase inhibitor dasatinib (Sprycel), an anticancer drug, is described. This commercially viable process yields dasatinib monohydrate free of potential impurities with consistent yield of 68% in route A and 61% in route B with HPLC purity >99.80% over four stages.

Scalable and impurity-free process for dasatinib: Src and BCR-Abl inhibitor

Buchappa,Sagar Vijay Kumar,Durga Prasad,Aparna

, p. 1621 - 1628 (2018/06/12)

An efficient, telescopic, impurity-free and scalable process for Bcr-Abl and Src family tyrosine kinase inhibitor for synthesis of Dasatinib with high yield and purity is described.

Dasatinib derivative with anti-tumor activity and application thereof

-

, (2017/07/12)

The invention belongs to the technical field of medicine chemistry and particularly relates to a dasatinib derivative with anti-tumor activity and application thereof. The dasatinib derivative provided by the invention has a very good inhibition effect on tyrosine kinase and has a very good application prospect for developing in the anti-tumor aspect.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 302964-02-9